Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:40 PM
Ignite Modification Date:
2025-12-24 @ 1:40 PM
NCT ID:
NCT01770795
Eligibility Criteria:
Inclusion Criteria:
* age over 18
* histologically or cytologically confirmted non-small cell lung cancer
* stage IIIb with pleural effusion or stage IV
* ECOG PS 0-2
* at least one measurable lesion
* expected life span more than 3 months
* normal bone marrow, liver, renal function
* no prior chemotherapy or radiotherapy except for whole brain radiotherapy for symptomatic brain metastases
* more than 6 months from the last adjuvant chemotherapy
Exclusion Criteria:
* active infection
* severe comorbitidies
* pregnant or lactating women
* other invasive malignancies
* poorly controlled symptomatic brain metastases
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01770795
Study Brief:
Protocol Section:
NCT01770795